WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke TRIGENESIS wurde als Wortmarke am 20.07.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1561675 |
| Länder | 
|
| Basismarke |
Nr. 88811637,
26. Februar 2020
|
| Anmeldedatum | 20. Juli 2020 |
| Ablaufdatum | 20. Juli 2030 |
Markeninhaber
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Markenvertreter
250 West 55th Street
New York NY 10019-9710
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform; pharmaceutical
preparations that modulate RNA expression; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations,
biological preparations and gene therapy products for the
treatment of genetic disorders and diseases
16
Printed materials, namely, brochures, leaflets, reports, and
newsletters on the topics of medicine, medical research,
scientific research, research and development of
pharmaceuticals, biological preparations and gene therapy
products, rare and infectious diseases, neuromuscular
diseases and disorders, muscular dystrophies, central
nervous system diseases and disorders, genetic diseases and
disorders, genetic therapy research, and diagnosis and
treatment of genetic disorders
42
Medical research; medical and scientific research services
all in the field of rare and infectious diseases; medical
and scientific research services all in the field of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, and genetic
diseases and disorders; medical and scientific research
services all in the field of gene therapy, gene editing,
genome editing, viruses, viral vectors, and viral
constructs; providing information in the field of medical
research, scientific research, research and development
relating to pharmaceuticals, biological preparations and
gene therapy products, rare and infectious diseases,
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, genetic therapy research, and
diagnosis and treatment of genetic disorders via a website
44
Medical information services; providing medical information
via a website; provision of health care services, namely,
providing information to doctors and patients regarding rare
diseases, medicines, health conditions and treatment
options
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 10. Januar 2023 | 2023/3 Gaz | CA | Ablehnung |
| 22. September 2022 | 2022/38 Gaz | JP | Ablehnung |
| 19. September 2022 | 2022/38 Gaz | MY | Ablehnung |
| 30. August 2022 | 2022/35 Gaz | NZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 23. Mai 2022 | 2022/21 Gaz | TH | Ablehnung |
| 09. Mai 2022 | 2022/19 Gaz | MX | Ablehnung |
| 04. April 2022 | 2022/14 Gaz | KR | Ablehnung |
| 29. März 2022 | 2022/14 Gaz | CA | Ablehnung |
| 28. März 2022 | 2022/13 Gaz | IS | Ablehnung |
| 27. Januar 2022 | 2022/4 Gaz | TR | Ablehnung |
| 13. Januar 2022 | 2022/2 Gaz | CO | Ablehnung |
| 10. Dezember 2021 | 2021/50 Gaz | BA | Ablehnung |
| 01. November 2021 | 2021/44 Gaz | KR | Ablehnung |
| 21. Oktober 2021 | 2021/42 Gaz | JP | Ablehnung |
| 19. Oktober 2021 | 2021/42 Gaz | CH | Ablehnung |
| 14. Oktober 2021 | 2021/41 Gaz | NO | Ablehnung |
| 04. Oktober 2021 | 2022/49 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. August 2021 | 2021/35 Gaz | UA | Ablehnung |
| 24. August 2021 | 2021/34 Gaz | BR | Ablehnung |
| 14. Juli 2021 | 2021/28 Gaz | GB | Ablehnung |
| 22. Juni 2021 | 2021/30 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 02. Juni 2021 | 2021/22 Gaz | DZ | Ablehnung |
| 06. Mai 2021 | 2021/18 Gaz | SG | Ablehnung |
| 14. April 2021 | 2021/15 Gaz | EM | Ablehnung |
| 22. März 2021 | 2021/13 Gaz | NZ | Ablehnung |
| 17. März 2021 | 2021/11 Gaz | CN | Ablehnung |
| 13. März 2021 | 2021/11 Gaz | AU | Ablehnung |
| 18. Februar 2021 | 2021/9 Gaz | IL | Ablehnung |
| 15. Februar 2021 | 2021/7 Gaz | RU | Ablehnung |
| 07. Dezember 2020 | 2020/51 Gaz | IN | Ablehnung |
| 20. Juli 2020 | 2020/46 Gaz | US | Eintragung |
ID: 141561675